logo

Apoptosis Assay Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The apoptosis assays market is segmented by Products (Assay Kits, Reagents, Instruments, and Microplates), Detection Technology, Application, End-User, and Geography

Home Industry Reports Healthcare Apoptosis Assay Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - ...

Market Snapshot

Apoptosis
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors attributing to the growth of the apoptosis assay market are the rising incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others. Rise in population suffering from chronic and autoimmune diseases are propelling the demand for market growth. In 2018, as per the AARDA (AMERICAN AUTOIMMUNE RELATED DISEASE ASSOCIATION) statistics, around 50 million Americans have an autoimmune disease, and this number is expected to rise in the future. And there are few more factors which are playing crucial roles in taking the apoptosis assay market to the next level, among them one is on-going developments related to apoptosis-modulating drugs which are expected to further propel the growth of the global apoptosis assays market. However, Increasing demand for high-content diagnosis and clinical research for cancer, in particular, is indeed bolstering market growth during the forecasted period.

Scope of the Report

Apoptosis is a form of programmed cell death that occurs in multicellular organisms. Apoptosis Assay aims to detect if a cell has apoptosis or not. It identifies and quantifies cell events related to programmed cell death, involving caspase initiation, phosphatidylserine (PS) cell surface exposure and DNA fragmentation.

By Product
Assay Kits
Annexin V
Caspase Assay
Others
Reagents
Instruments
Microplates
By Detection Technology
Spectrophotometry
Flow Cytometry
Cell Imaging and Analysis Systems
Other Technology
By Application
Stem Cell Research
Clinical and Diagnostics Application
Drug Discover and Development
Others
By End User
Pharmaceutical and Biotechnology Companies
Hospitla and Laboratories
Academic and Research Institutes
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Assay Kits Segment is Expected to Hold the Largest Market Share in the Apoptosis Assay Market

  • Assay kits identify and quantify cell events related to programmed cell death, involving caspase initiation, phosphatidylserine (PS) cell surface exposure and DNA fragmentation.
  • The number of repetitive consumption of assay in numerous other apoptosis processes can propel the demand of the assay kits during the forecast period.
  • The rising incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others is also boosting the market growth. As per the statistics from GLOBOCAN 2018, worldwide 18,078,957 individuals have cancer. Asia remains the leading contributor in the rising incidence of cancer with a reported share of 48.4% followed by Europe, North and Latin America, Africa, and Oceania with a share of 23.4%, 13.2% and 7.8%, 5.8%, and 1.4% respectively.
Picture2

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall apoptosis assay market, throughout the forecast period. This is owing to the factors such as the rising incidence of chronic diseases such as cancer and the availability of advanced healthcare infrastructure among the major factors. In North America region, the United States holds the largest market share owing to the factors such as increasing number of population suffering from autoimmune diseases and chronic disease, along with the rising geriatric population and developments related to apoptosis-modulating drugs in the country, is anticipated to stimulate the demand in this region.

Apoptosis Assay Market - Growth Rate by Region - Image

Competitive Landscape

The apoptosis assay market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market.  Ans some prominent players are vigorously making acquisitions and new product launches with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, GE Healthcare, and Becton, Dickinson and Company.

consolo

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidence of Chronic and Autoimmune Diseases

      2. 4.2.2 Developments Related to Apoptosis-Modulating Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Reforms

      2. 4.3.2 Expensive Detection Technology and High Capital Investment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Assay Kits

        1. 5.1.1.1 Annexin V

        2. 5.1.1.2 Caspase Assay

        3. 5.1.1.3 Others

      2. 5.1.2 Reagents

      3. 5.1.3 Instruments

      4. 5.1.4 Microplates

    2. 5.2 By Detection Technology

      1. 5.2.1 Spectrophotometry

      2. 5.2.2 Flow Cytometry

      3. 5.2.3 Cell Imaging and Analysis Systems

      4. 5.2.4 Other Technology

    3. 5.3 By Application

      1. 5.3.1 Stem Cell Research

      2. 5.3.2 Clinical and Diagnostics Application

      3. 5.3.3 Drug Discover and Development

      4. 5.3.4 Others

    4. 5.4 By End User

      1. 5.4.1 Pharmaceutical and Biotechnology Companies

      2. 5.4.2 Hospitla and Laboratories

      3. 5.4.3 Academic and Research Institutes

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific

      2. 6.1.2 Merck KGaA

      3. 6.1.3 Bio-Rad Laboratories

      4. 6.1.4 GE Healthcare

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Sartorius AG

      7. 6.1.7 GeneCopoeia, Inc.

      8. 6.1.8 BioTek Instruments

      9. 6.1.9 Bio-Techne Corporation

      10. 6.1.10 PerkinElmer Inc.

      11. 6.1.11 Promega Corporation

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Apoptosis Assay Market market is studied from 2018 - 2026.

The Apoptosis Assay Market is growing at a CAGR of 9.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Becton, Dickinson and Company are the major companies operating in Apoptosis Assay Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!